Insmed INSM Total costs & expenses

Total costs & expenses at other companies

Sarepta Therapeutics, Inc.SRPT

$387.96M-21.7%

United TherapeuticsUTHR

$452.5M+4.2%

ANI PharmaceuticalsANIP

$225.58M+14.2%

Regeneron PharmaceuticalsREGN

$3B+15.5%

MannkindMNKD

$109.72M+54.0%

FAQ

What is Insmed's total costs & expenses?

Insmed (INSM) reported total costs & expenses of $427.03M in Q2 2026.

How has Insmed's total costs & expenses changed year-over-year?

Insmed's total costs & expenses increased by 1.6% year-over-year, from $420.29M to $427.03M.

What is the long-term trend for Insmed's total costs & expenses?

Over 4 years (2021 to 2025), Insmed's total costs & expenses has grown at a 34.7% compound annual growth rate (CAGR), from $563.56M to $1.85B.

What does total costs & expenses mean?

The aggregate sum of all operating and non-operating costs incurred by the company during the reporting period, including cost of goods sold, research and development, and administrative expenses. It serves as a primary measure of the company's total resource consumption to sustain its business activities.